$32.96
-0.580 (-1.73%)
At Close: Jun 23, 2026
A Look at Hims & Hers Health Inc (HIMS) After 5.4% Decline -- GF Value $38.53 vs Price $33.54
07:59pm, Monday, 22'nd Jun 2026
On June 22, 2026, Hims and Hers Health Inc (HIMS) shares fell 5.4% today, trading at $33.54. Over the past 52 weeks, the stock has ranged from a low of $13.74 to
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Friday, 19'th Jun 2026
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
Hims & Hers Stock Jumps After Barclays Raises Price Target
02:17pm, Thursday, 18'th Jun 2026
Hims & Hers Health Inc. (NYSE:HIMS) shares are climbing after Barclays reiterated its bullish stance and lifted its price target from $29 to $39. Here's what you need to know.
Living Longer Is Big Business. These Stocks Will Benefit.
02:14pm, Thursday, 18'th Jun 2026
TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion.
Hims & Hers: The Bull Case Remains Strong
06:33am, Thursday, 18'th Jun 2026
Hims & Hers remains attractive at $33, supported by renewed Novo Nordisk partnership and unique access to patient demand. Despite weak Q1 2026 results—4% revenue growth, declining margins, and a net
Hims & Hers Health, Inc. (HIMS) Ascends While Market Falls: Some Facts to Note
06:46pm, Wednesday, 17'th Jun 2026
Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $31.89, moving +1.33% from the previous trading session.
Hims & Hers Enters A New Phase
06:08pm, Tuesday, 16'th Jun 2026
The Novo Nordisk partnership transformed Hims & Hers Health, Inc. from a fringe obesity player into an official healthcare ecosystem participant. Short interest remains elevated near 30%-32% of the HI
Hims & Hers Health Stock Slides Friday: What's Going On?
11:30am, Friday, 12'th Jun 2026
Hims & Hers Health Inc. (NYSE:HIMS) shares are trading lower on Friday as the stock digests last week's chief medical officer appointment and gives back some recent "repair rally" gains, even while ma
The GLP-1 stock nobody is pricing in isn't a drugmaker
09:30am, Thursday, 11'th Jun 2026
Scott Galloway and Ed Elson laid out the math on Prof G Markets and it should make every fast food shareholder uneasy: roughly 30 million Americans, about 1 in 8 US adults, are now on GLP-1s, and the
Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today
06:45pm, Wednesday, 10'th Jun 2026
Hims & Hers Health, Inc. (HIMS) closed at $27.71 in the latest trading session, marking a -4.38% move from the prior day.
OMCL vs. HIMS: Which Stock Is the Better Value Option?
12:41pm, Wednesday, 10'th Jun 2026
Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks is more attractive to value investors?
Hims & Hers Health (HIMS) Up 15.8% Since Last Earnings Report: Can It Continue?
12:31pm, Wednesday, 10'th Jun 2026
Hims & Hers Health (HIMS) reported earnings 30 days ago. What's next for the stock?
Is It Too Late to Buy Hims & Hers Health Inc (HIMS) After 3.7% Rally? GF Value Says Undervalued
07:17pm, Monday, 08'th Jun 2026
On June 08, 2026, Hims and Hers Health Inc (HIMS) shares rose 3.7% today to a current price of $27.17. The stock has traded within a 52-week range of $13.74 to $7
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know
10:01am, Monday, 08'th Jun 2026
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Great News: Wall Street Is Turning Bullish on This Troubled Telehealth Stock
08:45am, Friday, 05'th Jun 2026
This telehealth stock has fallen hard, but its GLP-1 shift and global expansion could reshape the long-term story. Is the market too skeptical or still too optimistic?
Sign In
Buy HIMS